These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 30219991)

  • 21. Underutilization of warfarin for stroke prophylaxis in patients with atrial fibrillation or atrial flutter in Korea.
    Lee IH; Kim H; Je NK
    J Cardiol; 2015 Dec; 66(6):475-81. PubMed ID: 26242197
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adherence to treatment guidelines: the association between stroke risk stratified comparing CHADS
    Chapman SA; St Hill CA; Little MM; Swanoski MT; Scheiner SR; Ware KB; Lutfiyya MN
    BMC Health Serv Res; 2017 Feb; 17(1):127. PubMed ID: 28187730
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quality of Warfarin Anticoagulation in Indigenous and Non-Indigenous Australians With Atrial Fibrillation.
    Nguyen MT; Gallagher C; Pitman BM; Emami M; Kadhim K; Hendriks JM; Middeldorp ME; Roberts-Thomson KC; Mahajan R; Lau DH; Sanders P; Wong CX
    Heart Lung Circ; 2020 Aug; 29(8):1122-1128. PubMed ID: 31980393
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relation of Race, Apparent Disability, and Stroke Risk With Warfarin Prescribing for Atrial Fibrillation in Patients Receiving Maintenance Hemodialysis.
    Wetmore JB; Peng Y; Gilbertson DT; Liu J
    Am J Cardiol; 2019 Feb; 123(4):598-604. PubMed ID: 30527770
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Racial and ethnic differences in the prevalence, management, and outcomes in patients with atrial fibrillation: A systematic review.
    Ugowe FE; Jackson LR; Thomas KL
    Heart Rhythm; 2018 Sep; 15(9):1337-1345. PubMed ID: 29803022
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Racial/ethnic differences in the risk of intracranial hemorrhage among patients with atrial fibrillation.
    Shen AY; Yao JF; Brar SS; Jorgensen MB; Chen W
    J Am Coll Cardiol; 2007 Jul; 50(4):309-15. PubMed ID: 17659197
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Edoxaban Versus Warfarin in Atrial Fibrillation Patients at Risk of Falling: ENGAGE AF-TIMI 48 Analysis.
    Steffel J; Giugliano RP; Braunwald E; Murphy SA; Mercuri M; Choi Y; Aylward P; White H; Zamorano JL; Antman EM; Ruff CT
    J Am Coll Cardiol; 2016 Sep; 68(11):1169-1178. PubMed ID: 27609678
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Factors associated with non-vitamin K antagonist oral anticoagulants for stroke prevention in patients with new-onset atrial fibrillation: Results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II (ORBIT-AF II).
    Steinberg BA; Shrader P; Thomas L; Ansell J; Fonarow GC; Gersh BJ; Hylek E; Kowey PR; Mahaffey KW; O'Brien EC; Singer DE; Peterson ED; Piccini JP;
    Am Heart J; 2017 Jul; 189():40-47. PubMed ID: 28625380
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anxiety, Depression, and Adverse Clinical Outcomes in Patients With Atrial Fibrillation Starting Warfarin: Cardiovascular Research Network WAVE Study.
    Baumgartner C; Fan D; Fang MC; Singer DE; Witt DM; Schmelzer JR; Williams MS; Gurwitz JH; Sung SH; Go AS
    J Am Heart Assoc; 2018 Apr; 7(8):. PubMed ID: 29656278
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Is rivaroxaban associated with lower inpatient costs compared to warfarin among patients with non-valvular atrial fibrillation?
    Laliberté F; Pilon D; Raut MK; Nelson WW; Olson WH; Germain G; Schein JR; Lefebvre P
    Curr Med Res Opin; 2014 Aug; 30(8):1521-8. PubMed ID: 24758611
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Real-world comparative effectiveness and safety of rivaroxaban and warfarin in nonvalvular atrial fibrillation patients.
    Laliberté F; Cloutier M; Nelson WW; Coleman CI; Pilon D; Olson WH; Damaraju CV; Schein JR; Lefebvre P
    Curr Med Res Opin; 2014 Jul; 30(7):1317-25. PubMed ID: 24650301
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quality of care for atrial fibrillation among patients hospitalized for heart failure.
    Piccini JP; Hernandez AF; Zhao X; Patel MR; Lewis WR; Peterson ED; Fonarow GC;
    J Am Coll Cardiol; 2009 Sep; 54(14):1280-9. PubMed ID: 19778670
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High-sensitivity troponin T and risk stratification in patients with atrial fibrillation during treatment with apixaban or warfarin.
    Hijazi Z; Wallentin L; Siegbahn A; Andersson U; Alexander JH; Atar D; Gersh BJ; Hanna M; Harjola VP; Horowitz JD; Husted S; Hylek EM; Lopes RD; McMurray JJ; Granger CB;
    J Am Coll Cardiol; 2014 Jan 7-14; 63(1):52-61. PubMed ID: 24055845
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Outcomes in a Warfarin-Treated Population With Atrial Fibrillation.
    Björck F; Renlund H; Lip GY; Wester P; Svensson PJ; Själander A
    JAMA Cardiol; 2016 May; 1(2):172-80. PubMed ID: 27437888
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence and quality of warfarin use for patients with atrial fibrillation in the long-term care setting.
    McCormick D; Gurwitz JH; Goldberg RJ; Becker R; Tate JP; Elwell A; Radford MJ
    Arch Intern Med; 2001 Nov; 161(20):2458-63. PubMed ID: 11700158
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The impact of risk score (CHADS2 versus CHA2DS2-VASc) on long-term outcomes after atrial fibrillation ablation.
    Jacobs V; May HT; Bair TL; Crandall BG; Cutler M; Day JD; Weiss JP; Osborn JS; Muhlestein JB; Anderson JL; Mallender C; Bunch TJ
    Heart Rhythm; 2015 Apr; 12(4):681-6. PubMed ID: 25546809
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anticoagulation for stroke prevention in elderly patients with atrial fibrillation, including those with falls and/or early-stage dementia: a single-center, retrospective, observational study.
    Jacobs LG; Billett HH; Freeman K; Dinglas C; Jumaquio L
    Am J Geriatr Pharmacother; 2009 Jun; 7(3):159-66. PubMed ID: 19616184
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Population-Based Long-Term Impact of Anticoagulant and Antiplatelet Therapies in Low-Risk Patients With Atrial Fibrillation.
    Golive A; May HT; Bair TL; Jacobs V; Crandall BG; Cutler MJ; Day JD; Mallender C; Osborn JS; Stevens SM; Weiss JP; Woller SC; Bunch TJ
    Am J Cardiol; 2017 Jul; 120(1):75-82. PubMed ID: 28483209
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of Depression and Adherence to Oral Anticoagulation in Patients With Atrial Fibrillation.
    Lapa ME; Swabe GM; Magnani JW
    J Am Heart Assoc; 2023 Nov; 12(22):e031281. PubMed ID: 37982265
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effectiveness and safety of dabigatran and warfarin in real-world US patients with non-valvular atrial fibrillation: a retrospective cohort study.
    Lauffenburger JC; Farley JF; Gehi AK; Rhoney DH; Brookhart MA; Fang G
    J Am Heart Assoc; 2015 Apr; 4(4):. PubMed ID: 25862791
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.